Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Tumor-induced erythroid precursor-differentiated myeloid cells mediate immunosuppression and curtail anti-PD-1/PD-L1 treatment efficacy
Haixia Long, Qingzhu Jia, Liuyang Wang, et al.
Cancer Cell (2022) Vol. 40, Iss. 6, pp. 674-693.e7
Open Access | Times Cited: 86

Showing 1-25 of 86 citing articles:

Regulatory mechanisms of PD-1/PD-L1 in cancers
Xin Lin, Kuan Kang, Pan Chen, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 96
An Activatable Phototheranostic Probe for Anti‐hypoxic Type I Photodynamic‐ and Immuno‐Therapy of Cancer
Min Zhao, Yuyang Zhang, Jia Miao, et al.
Advanced Materials (2023) Vol. 36, Iss. 4
Closed Access | Times Cited: 60
Mechanisms of resistance to targeted therapy and immunotherapy in non-small cell lung cancer: promising strategies to overcoming challenges
Yuchu Xiang, Xudong Liu, Yifan Wang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 23
CD8 + T cell exhaustion in anti‐tumour immunity: The new insights for cancer immunotherapy
Yijin Huang, Anna Jia, Yufei Wang, et al.
Immunology (2022) Vol. 168, Iss. 1, pp. 30-48
Open Access | Times Cited: 49
Origin and Heterogeneity of Tissue Myeloid Cells: A Focus on GMP-Derived Monocytes and Neutrophils
Lai Guan Ng, Zhaoyuan Liu, Immanuel Kwok, et al.
Annual Review of Immunology (2023) Vol. 41, Iss. 1, pp. 375-404
Open Access | Times Cited: 37
Evolution and Progress of mRNA Vaccines in the Treatment of Melanoma: Future Prospects
Dimitrios Bafaloukos, Ioanna Gazouli, Christos Koutserimpas, et al.
Vaccines (2023) Vol. 11, Iss. 3, pp. 636-636
Open Access | Times Cited: 30
Tumor-associated myeloid cells in cancer immunotherapy
Xinyu Cheng, Huilan Wang, Zhongyu Wang, et al.
Journal of Hematology & Oncology (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 29
Regulating lactate-related immunometabolism and EMT reversal for colorectal cancer liver metastases using shikonin targeted delivery
Long Li, Wei Xiong, Fenwang Lin, et al.
Journal of Experimental & Clinical Cancer Research (2023) Vol. 42, Iss. 1
Open Access | Times Cited: 28
Acquired resistance to anti-PD1 therapy in patients with NSCLC associates with immunosuppressive T cell phenotype
Stefanie Hiltbrunner, Lena Cords, Sabrina Kasser, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 22
Targets of tumor microenvironment for potential drug development
Ling Zhang, Ziruoyu Wang, Kailu Liu, et al.
MedComm – Oncology (2024) Vol. 3, Iss. 1
Open Access | Times Cited: 10
The complexity of immune evasion mechanisms throughout the metastatic cascade
Nicole M. Haynes, Thomas B Chadwick, Belinda S. Parker
Nature Immunology (2024) Vol. 25, Iss. 10, pp. 1793-1808
Closed Access | Times Cited: 9
Erythroid progenitor cell–mediated spleen–tumor interaction deteriorates cancer immunity
Zhi‐Zhong Wu, Wei‐Wei Deng, Su‐Wen Zhu, et al.
Proceedings of the National Academy of Sciences (2025) Vol. 122, Iss. 9
Open Access | Times Cited: 1
Targeting tumour-reprogrammed myeloid cells: the new battleground in cancer immunotherapy
Francesco De Sanctis, Annalisa Adamo, Stefania Canè, et al.
Seminars in Immunopathology (2022) Vol. 45, Iss. 2, pp. 163-186
Open Access | Times Cited: 33
CD200 + cytotoxic T lymphocytes in the tumor microenvironment are crucial for efficacious anti–PD-1/PD-L1 therapy
Xinxin Wang, Haoran Zha, Wei Wu, et al.
Science Translational Medicine (2023) Vol. 15, Iss. 679
Closed Access | Times Cited: 20
Targeting the epigenome to reinvigorate T cells for cancer immunotherapy
Dian Xiong, Lu Zhang, Zhi‐Jun Sun
Military Medical Research (2023) Vol. 10, Iss. 1
Open Access | Times Cited: 20
CD71+erythroid cells suppress T-cell effector functions and predict immunotherapy outcomes in patients with virus-associated solid tumors
Najmeh Bozorgmehr, Isobel Okoye, Siavash Mashhouri, et al.
Journal for ImmunoTherapy of Cancer (2023) Vol. 11, Iss. 5, pp. e006595-e006595
Open Access | Times Cited: 18
The immunosuppressive landscape in tumor microenvironment
Wuyi Liu, Huyue Zhou, Wenjing Lai, et al.
Immunologic Research (2024) Vol. 72, Iss. 4, pp. 566-582
Closed Access | Times Cited: 7
A logic-incorporated gene regulatory network deciphers principles in cell fate decisions
Gang Xue, X. Zhang, Wanqi Li, et al.
eLife (2024) Vol. 12
Open Access | Times Cited: 6
Nutritional status as prognostic factor of advanced oesophageal cancer patients treated with immune checkpoint inhibitors
Ning Chen, Ying Yu, Wanji Shen, et al.
Clinical Nutrition (2023) Vol. 43, Iss. 1, pp. 142-153
Open Access | Times Cited: 15
Bone serves as a transfer station for secondary dissemination of breast cancer
Yufan Huang, Hongli Wang, Xiaomin Yue, et al.
Bone Research (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 13
Unraveling the pathogenesis of bone marrow hematopoietic injury and the therapeutic potential of natural products
Jing Long, Heng-Zhou Lai, Y. Q. Huang, et al.
Pharmacological Research (2025), pp. 107589-107589
Open Access
Myeloid cells: key players in tumor microenvironments
Qiaomin Hua, Zhixiong Li, Yulan Weng, et al.
Frontiers of Medicine (2025)
Closed Access
PD-1/CTLA-4 antibody AK104 in advanced solid tumors after PD/PD-L1 treatment failure: A retrospective cohort study
Jun Yi, Herbert Yu, Yun Shu, et al.
Medicine (2025) Vol. 104, Iss. 10, pp. e41548-e41548
Open Access
Tumor immune evasion: Systemic immunosuppressive networks beyond the local microenvironment
Chengsong Yan, Xiao‐Fan Wang
Proceedings of the National Academy of Sciences (2025) Vol. 122, Iss. 12
Open Access
DNA methylation-regulated HLA-C expression modulates immune responses and metabolic alterations to influence prognosis in mesothelioma
Huilin Zhang, Liang Yu, Yue Guo, et al.
Cancer Immunology Immunotherapy (2025) Vol. 74, Iss. 5
Open Access
Page 1 - Next Page

Scroll to top